Stryker Analyst Ratings
Barclays Maintains Stryker Corp(SYK.US) With Buy Rating, Maintains Target Price $443
A Quick Look at Today's Ratings for Stryker Corp(SYK.US), With a Forecast Between $390 to $465
Truist Raises Price Target on Stryker to $400 From $390, Keeps Hold Rating
Stryker Analyst Ratings
Nephron Research Adjusts Stryker Price Target to $450 From $465
Roth MKM Maintains Stryker Corp(SYK.US) With Buy Rating, Raises Target Price to $456
TD Cowen Maintains Stryker Corp(SYK.US) With Buy Rating, Maintains Target Price $435
BTIG Maintains Stryker Corp(SYK.US) With Buy Rating, Cuts Target Price to $403
Truist Financial Maintains Stryker Corp(SYK.US) With Hold Rating, Announces Target Price $390
Truist Cuts Price Target on Stryker to $390 From $413, Keeps Hold Rating
CCORF Maintains Stryker Corp(SYK.US) With Buy Rating, Maintains Target Price $435
Evercore ISI Adjusts Stryker Price Target to $400 From $410, Maintains Outperform Rating
Goldman Sachs Adjusts Price Target on Stryker to $403 From $422, Keeps Neutral Rating
Needham Maintains Stryker Corp(SYK.US) With Buy Rating, Maintains Target Price $442
Stryker Analyst Ratings
Needham Reiterates Buy on Stryker, Maintains $442 Price Target
Jefferies Maintains Stryker Corp(SYK.US) With Buy Rating, Maintains Target Price $465
Truist Financial Maintains Stryker Corp(SYK.US) With Hold Rating
RBC Capital Maintains Stryker Corp(SYK.US) With Buy Rating, Maintains Target Price $435